Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Pharmagen Appoints Industry Veteran Russell Skibsted as Chief Financial Officer ("CFO ") PR Newswire SILVER SPRING, Md., June 11, 2014 SILVER SPRING, Md., June 11, 2014 /PRNewswire/...
Pharmagen Appoints Additional Members to its Board of Directors PR Newswire SILVER SPRING, Md., May 29, 2014 SILVER SPRING, Md., May 29, 2014 /PRNewswire/ -- Pharmagen, Inc. (OTCPink: PHRX) (the...
Pharmagen Recruits Frederick W. Mundt as Senior Vice President of Sales PR Newswire SILVER SPRING, Md., May 6, 2014 SILVER SPRING, Md., May 6, 2014 /PRNewswire/ -- Pharmagen, Inc. (OTCPINK: PHRX...
Boyd Relac joins the Pharmagen Executive Team as Chief Operating Officer ("COO") PR Newswire SILVER SPRING, Md., April 29, 2014 SILVER SPRING, Md., April 29, 2014 /PRNewswire/...
Pharmagen Completes Bridge Financing to Support Consolidation and Capital Restructure Plan PR Newswire SILVER SPRING, Md., April 22, 2014 SILVER SPRING, Md., April 22, 2014 /PRNewswire/...
Pharmagen Partners with Bagel Boy Equity Group II, LLC and prepares to Launch its Industry Consolidation Strategy PR Newswire SILVER SPRING, Md., Dec. 17, 2013 SILVER SPRING, Md., Dec. 17, 2013...
Pharmagen Announces Third Quarter 2013 Results PR Newswire SILVER SPRING, Md., Nov. 14, 2013 SILVER SPRING, Md., Nov. 14, 2013 /PRNewswire/ -- Pharmagen, Inc. (OTCQB: PHRX) (the "Company" or...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 7442 | 1.0E-6 | CS |
| 12 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 11179 | 1.0E-6 | CS |
| 26 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 8719 | 1.0E-6 | CS |
| 52 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 8407 | 1.0E-6 | CS |
| 156 | 0 | 0 | 1.0E-6 | 0.0003 | 1.0E-6 | 12661 | 4.03E-5 | CS |
| 260 | -0.000699 | -99.8571428571 | 0.0007 | 0.0039 | 1.0E-6 | 212478 | 0.0006274 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
